Fluorescent Cellulose Wipe as a New and Sustainable Light-Activated Antibacterial and Antiviral Agent
Source abstract
Abstract
The ongoing global COVID-19 pandemic has created awareness toward the development of antibacterial and antiviral materials. In this communication, we report a new and promising antibacterial and antiviral material based on cationic conjugated oligomer electrolytes with imidazole groups (c-OPE-Im) and 1,4-diazabicyclo [2,2,2]-octane pendant groups (c-OPE-DABCO) and a cellulose wipe via a simple dip-coating process. Specific interactions between c-OPE and the cellulose wipe such as the ion-dipole and electrostatic interactions drive the successful coating process, resulting in highly fluorescent materials. The c-OPE-Im coated wipe possesses impressive killing efficiency against Escherichia coli (E. coli) under 5–10 min light-activation. The generation of reactive oxygen species from both “free” c-OPE delivered from the coated wipe and undelivered OPE is proposed to be the antibacterial mechanism. The c-OPE coated wipe also exhibited an appreciable inactivation of SARS-CoV-2, where a total inactivation was achieved in 20–30 min light-activation. The simple preparation, sustainable nature of the cellulose wipe, and promising antibacterial and antiviral performance make the current surface-coated wipes attractive as a new antibacterial and antiviral agent.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Polydiacetylene-based materials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry and Chemical Biology, University of New Mexico, Albuquerque, New Mexico 87131, United States
Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131, United States
Funding
Biosafe Technologies LLC · US National Institutes of Health
References (27)
Show source-provided references
1. 10.1002/adfm.20180214010.1002/adfm.201802140 ↗
2. 10.1002/adma.20190410610.1002/adma.201904106 ↗
3. 10.1016/j.bcab.2016.05.00210.1016/j.bcab.2016.05.002 ↗
4. 10.1016/j.btre.2020.e0042710.1016/j.btre.2020.e00427 ↗
5. 10.1021/acsabm.1c0007710.1021/acsabm.1c00077 ↗
6. 10.1039/b311900a10.1039/b311900a ↗
7. 10.1039/C8PP00534F10.1039/C8PP00534F ↗
8. 10.5978/islsm.27_18-RA-0110.5978/islsm.27_18-RA-01 ↗
9. 10.1039/b502125a10.1039/b502125a ↗
10. 10.1002/adhm.20190013210.1002/adhm.201900132 ↗
11. 10.1021/acs.langmuir.8b0181010.1021/acs.langmuir.8b01810 ↗
12. 10.1021/ar50004a00210.1021/ar50004a002 ↗
13. 10.1021/j100172a03810.1021/j100172a038 ↗
14. 10.1073/pnas.061132810410.1073/pnas.0611328104 ↗
15. 10.1021/am200644g10.1021/am200644g ↗
16. 10.1021/jz101088k10.1021/jz101088k ↗
17. 10.1016/j.colsurfb.2014.01.03310.1016/j.colsurfb.2014.01.033 ↗
18. 10.1016/j.colsurfb.2014.12.04310.1016/j.colsurfb.2014.12.043 ↗
19. 10.1021/acs.chemmater.7b0179610.1021/acs.chemmater.7b01796 ↗
20. 10.1111/php.1301310.1111/php.13013 ↗
21. 10.1021/acsami.6b1624310.1021/acsami.6b16243 ↗
22. 10.1016/0166-6622(89)80243-410.1016/0166-6622(89)80243-4 ↗
23. 10.1016/j.jviromet.2014.10.00810.1016/j.jviromet.2014.10.008 ↗
24. 10.1021/jp983921t10.1021/jp983921t ↗
25. 10.1038/nmat75010.1038/nmat750 ↗
26. 10.1016/j.addr.2012.02.00310.1016/j.addr.2012.02.003 ↗
27. 10.1021/la401983h10.1021/la401983h ↗